Over the past few months, a wave of government attorneys has flooded the lateral market, creating a rare hiring opportunity ...

CFO Beth Jantzen reported total revenues of $1.2 million for Q1 2025, a year-over-year increase driven by higher product revenue from DNA Tagging and increased isotopic testing services. Operating ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Inc. reported its Q4 2024 earnings, revealing a notable miss in both earnings per share (EPS) and revenue compared to analysts' forecasts. The company posted an EPS of $0.64, falling short of the ...

Look at some companies that have a monopolistic place in the marketplace and decide whether it's a good idea to invest in them. The list is populated with some big names.

With marketing spending expected to reach historic highs, it’s important for marketers to ensure that every dollar invested ...